Affigen
A St. Louis startup developing drugs that target specific molecules in cancerous tumors.
Operating in biotechnology, medical, pharmaceutical based in Midwestern US, Affigen was founded in 2016.
Affigen is positioned in biotechnology, medical, pharmaceutical, a segment that rewards a clear, focused offering.
Midwestern US is where the company is located.
The company is listed at the Series_A stage of development.
Its team size is recorded as c_00001_00010 employees.
Total disclosed funding stands at about $17M.
| Sector | Biotechnology, Medical, Pharmaceutical |
|---|---|
| Headquarters | Midwestern US |
| Founded | 2016 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $17,000,000 |
Website: www.affigen.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account